⌘K
Loading ticker…
As of 2026-08-24, Vanda Pharmaceuticals Inc. (VNDA) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 0.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
VNDA is held by 25 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 52 ETFs · $64M across latest filings · largest weight 0.90% (MEDX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VTWO | 0.01% | $2M | — |
| VFMO | 0.09% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| AVSC | 0.03% | $875K | −0.02 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.10% |
| $653K |
| — |
| SBIO | 0.24% | $393K | −0.10 pp |
| FSCC | 0.12% | $337K | −0.06 pp |
| VTWV | 0.02% | $292K | — |
| GSSC | 0.03% | $273K | −0.02 pp |
Showing 10 of 25 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VNDA Jan avg: -8.30% median: -11.22% win: 25% σ: 8.74% n: 4 2022-04-12 → 2026-07-31 | VNDA Feb avg: 8.53% median: 13.05% win: 75% σ: 17.76% n: 4 2022-04-12 → 2026-07-31 | VNDA Mar avg: -7.16% median: -5.81% win: 25% σ: 11.63% n: 4 2022-04-12 → 2026-07-31 | VNDA Apr avg: -1.02% median: -1.74% win: 40% σ: 11.18% n: 5 2022-04-12 → 2026-07-31 | VNDA May avg: -1.92% median: -3.09% win: 20% σ: 6.00% n: 5 2022-04-12 → 2026-07-31 | VNDA Jun avg: 7.17% median: 10.57% win: 80% σ: 6.92% n: 5 2022-04-12 → 2026-07-31 | VNDA Jul avg: -7.29% median: -9.75% win: 20% σ: 8.23% n: 5 2022-04-12 → 2026-07-31 | VNDA Aug avg: -2.61% median: -5.64% win: 25% σ: 9.84% n: 4 2022-04-12 → 2026-07-31 (current) | VNDA Sep avg: -7.31% median: -8.98% win: 25% σ: 9.49% n: 4 2022-04-12 → 2026-07-31 | VNDA Oct avg: -1.58% median: 0.27% win: 50% σ: 8.02% n: 4 2022-04-12 → 2026-07-31 | VNDA Nov avg: 5.78% median: 7.48% win: 75% σ: 15.98% n: 4 2022-04-12 → 2026-07-31 | VNDA Dec avg: 9.69% median: 3.23% win: 50% σ: 41.08% n: 4 2022-04-12 → 2026-07-31 |